Literature DB >> 28032314

Potential Mechanisms Underlying the Therapeutic Effects of Electroconvulsive Therapy.

Jiangling Jiang1, Jijun Wang1,2,3, Chunbo Li4,5,6.   

Abstract

In spite of the extensive application of electroconvulsive therapy (ECT), how it works remains unclear. So far, researchers have made great efforts in figuring out the mechanisms underlying the effect of ECT treatment via determining the levels of neurotransmitters and cytokines and using genetic and epigenetic tools, as well as structural and functional neuroimaging. To help address this question and provide implications for future research, relevant clinical trials and animal experiments are reviewed.

Keywords:  Electroconvulsive therapy; Epigenetics; Inflammatory factors; Neuroimaging; Neurotransmitters; Neurotrophins

Mesh:

Substances:

Year:  2016        PMID: 28032314      PMCID: PMC5567510          DOI: 10.1007/s12264-016-0094-x

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  130 in total

1.  Electroconvulsive therapy has acute immunological and neuroendocrine effects in patients with major depressive disorder.

Authors:  Sjoerd B A H A Fluitman; Cobi J Heijnen; Damiaan A J P Denys; Willem A Nolen; Ferdi J Balk; Herman G M Westenberg
Journal:  J Affect Disord       Date:  2010-12-22       Impact factor: 4.839

2.  Effects of COMT, DRD2, BDNF, and APOE Genotypic Variation on Treatment Efficacy and Cognitive Side Effects of Electroconvulsive Therapy.

Authors:  Chad A Bousman; Natalie Katalinic; Donel M Martin; Deidre J Smith; Anna Ingram; Nathan Dowling; Chee Ng; Colleen K Loo
Journal:  J ECT       Date:  2015-06       Impact factor: 3.635

3.  Contemporary use and practice of electroconvulsive therapy worldwide.

Authors:  Kari Ann Leiknes; Lindy Jarosh-von Schweder; Bjørg Høie
Journal:  Brain Behav       Date:  2012-05       Impact factor: 2.708

4.  Asymmetric alternation of the hemodynamic response at the prefrontal cortex in patients with schizophrenia during electroconvulsive therapy: a near-infrared spectroscopy study.

Authors:  Yasutaka Fujita; Minoru Takebayashi; Kazue Hisaoka; Mami Tsuchioka; Shigeru Morinobu; Shigeto Yamawaki
Journal:  Brain Res       Date:  2011-06-29       Impact factor: 3.252

5.  Electroconvulsive therapy and biomarkers of neuronal injury and plasticity: Serum levels of neuron-specific enolase and S-100b protein.

Authors:  Johanna Palmio; Martti Huuhka; Seppo Laine; Heini Huhtala; Jukka Peltola; Esa Leinonen; Jaana Suhonen; Tapani Keränen
Journal:  Psychiatry Res       Date:  2010-04-08       Impact factor: 3.222

6.  S100 and impact of ECT on depression and cognition.

Authors:  Baer Arts; Maarten Peters; Rudolf Ponds; Adriaan Honig; Paul Menheere; Jim van Os
Journal:  J ECT       Date:  2006-09       Impact factor: 3.635

Review 7.  Emotional valence modulates brain functional abnormalities in depression: evidence from a meta-analysis of fMRI studies.

Authors:  Nynke A Groenewold; Esther M Opmeer; Peter de Jonge; André Aleman; Sergi G Costafreda
Journal:  Neurosci Biobehav Rev       Date:  2012-12-01       Impact factor: 8.989

Review 8.  Imaging predictors of remission to anti-depressant medications in major depressive disorder.

Authors:  Kee F Chi; Mayuresh Korgaonkar; Stuart M Grieve
Journal:  J Affect Disord       Date:  2015-07-21       Impact factor: 4.839

9.  Neuropathologic examination after 91 ECT treatments in a 92-year-old woman with late-onset depression.

Authors:  Jason Scalia; Sarah H Lisanby; Andrew J Dwork; James E Johnson; Elisabeth R Bernhardt; Victoria Arango; W Vaughn McCall
Journal:  J ECT       Date:  2007-06       Impact factor: 3.635

10.  Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies.

Authors:  Brisa S Fernandes; Marc L Molendijk; Cristiano A Köhler; Jair C Soares; Cláudio Manuel G S Leite; Rodrigo Machado-Vieira; Thamara L Ribeiro; Jéssica C Silva; Paulo M G Sales; João Quevedo; Viola Oertel-Knöchel; Eduard Vieta; Ana González-Pinto; Michael Berk; André F Carvalho
Journal:  BMC Med       Date:  2015-11-30       Impact factor: 8.775

View more
  6 in total

1.  Is Electroconvulsive Therapy a Treatment for Depression Following Traumatic Brain Injury?

Authors:  Anja Srienc; Puneet Narang; Simrat Sarai; Yee Xiong; Steven Lippmann
Journal:  Innov Clin Neurosci       Date:  2018-04-01

2.  [Ethics, evidence and electroconvulsive therapy].

Authors:  D Zilles; M Koller; I Methfessel; S Trost; A Simon
Journal:  Nervenarzt       Date:  2018-07       Impact factor: 1.214

Review 3.  Updated Review on the Clinical Use of Repetitive Transcranial Magnetic Stimulation in Psychiatric Disorders.

Authors:  Qian Guo; Chunbo Li; Jijun Wang
Journal:  Neurosci Bull       Date:  2017-10-24       Impact factor: 5.203

4.  Electroconvulsive therapy, electric field, neuroplasticity, and clinical outcomes.

Authors:  Zhi-De Deng; Miklos Argyelan; Jeremy Miller; Davin K Quinn; Megan Lloyd; Thomas R Jones; Joel Upston; Erik Erhardt; Shawn M McClintock; Christopher C Abbott
Journal:  Mol Psychiatry       Date:  2021-12-01       Impact factor: 13.437

5.  Hippocampal-subregion functional alterations associated with antidepressant effects and cognitive impairments of electroconvulsive therapy.

Authors:  Tongjian Bai; Qiang Wei; Wen Xie; Anzhen Wang; Jiaojian Wang; Gong-Jun Ji; Kai Wang; Yanghua Tian
Journal:  Psychol Med       Date:  2018-09-19       Impact factor: 7.723

6.  Electroconvulsive stimulation attenuates chronic neuroinflammation.

Authors:  Smadar Goldfarb; Nina Fainstein; Tamir Ben-Hur
Journal:  JCI Insight       Date:  2020-09-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.